Avivagen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Avivagen generated cash of -$3,116,538, which is more than the previous year. Cash used in financing activities reached the amount of $1,999,104 last year. Net change in cash is therefore -$1,117,833.
Cash Flow
| 2013 | -2.65M | 0 | 3.51M |
|---|---|---|---|
| 2014 | -1.76M | 0 | 1.49M |
| 2015 | -1.64M | 0 | 1.50M |
| 2016 | -2.18M | 0 | 6.69M |
| 2017 | -4.77M | 0 | 1.22M |
| 2018 | -3.80M | -69.53K | 4.48M |
| 2019 | -3.52M | -109.20K | 2.50M |
| 2020 | -3.33M | -44.29K | 2.96M |
| 2021 | -4.59M | -8.70K | 5.34M |
| 2022 | -3.11M | 0 | 1.99M |
VIV.V Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.40M | 664.16K | 1.08M | 2.20M | 1.60M | 5.14M | 632.24K | 768.79K | 1.04M | 184.17K |
Operating activities | ||||||||||
Net income | -6.06M | -6.39M | -4.75M | -4.83M | -4.83M | -5.04M | -2.75M | 0 | -2.09M | -2.02M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 87.49K | 124.77K | 127.49K | 4.63K | 2.54K | 0 | 11.72K | 20.82K | 33.09K | 68.16K |
Stock-based compensation expense | 151.61K | 326.81K | 318.80K | 317.90K | 0 | 308.16K | 194.78K | 166.55K | 177.86K | 726.95K |
| Deferred income tax benefit | 151.61K | 326.81K | 318.80K | 317.90K | 0 | 308.16K | 194.78K | 166.55K | 177.86K | 726.95K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -134.32K | 172.22K | -477.61K | 93.79K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 219.52K | -826.01K | 45.75K | 127.48K | -488.58K | -87.91K | -1.5K | 17.26K | 57.73K | -75.99K |
Accounts payable | 639.90K | -228.38K | 232.01K | -206.37K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -3.11M | -4.59M | -3.33M | -3.52M | -3.80M | -4.77M | -2.18M | -1.64M | -1.76M | -2.65M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -8.70K | -44.29K | -109.20K | -69.53K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -8.70K | -44.29K | -109.20K | -69.53K | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 4.02M | 7.5M | 3M | 1.07M | 4.05M | 0 | 6.04M | 1.5M | 1.41M | 3.76M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -1.22M | -64.18K | 0 | -91.56K | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.99M | 5.34M | 2.96M | 2.50M | 4.48M | 1.22M | 6.69M | 1.50M | 1.49M | 3.51M |
Net Change In Cash | -1.11M | 744.12K | -421.77K | -1.12M | 607.25K | -3.54M | 4.51M | -136.54K | -276.88K | 861.50K |
Cash at end of period | 290.45K | 1.40M | 664.16K | 1.08M | 2.20M | 1.60M | 5.14M | 632.24K | 768.79K | 1.04M |